Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Clinical/translational cancer immunotherapy

Short report

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

Online download statistics by month:

Online download statistics by month: March 2020 to March 2024

	Abstract	Full	Pdf
Mar 2020	251	251	72
Apr 2020	226	226	112
May 2020	69	69	76
Jun 2020	85	85	45
Jul 2020	81	81	33
Aug 2020	65	65	60
Sep 2020	85	85	46
Oct 2020	92	92	82
Nov 2020	89	88	45
Dec 2020	114	114	42
Jan 2021	203	203	36
Feb 2021	145	145	44
Mar 2021	140	140	34
Apr 2021	97	97	34
May 2021	91	91	23
Jun 2021	85	85	25
Jul 2021	60	60	22
Aug 2021	84	84	39
Sep 2021	74	74	38
Oct 2021	64	64	32
Nov 2021	64	64	29
Dec 2021	61	62	28
Jan 2022	174	175	16
Feb 2022	58	66	21
Mar 2022	77	84	37
Apr 2022	85	99	39
May 2022	96	96	20
Jun 2022	73	73	19
Jul 2022	58	73	24
Aug 2022	76	77	19
Sep 2022	66	71	47
Oct 2022	59	63	30
Nov 2022	59	108	26
Dec 2022	71	72	27
Jan 2023	50	50	11
Feb 2023	73	75	14
Mar 2023	92	93	23
Apr 2023	36	37	15
May 2023	41	41	17
Jun 2023	57	57	17
Jul 2023	51	51	23
Aug 2023	40	40	14
Sep 2023	44	45	11
Oct 2023	59	59	23
Nov 2023	45	45	15
Dec 2023	56	56	18
Jan 2024	45	46	25
Feb 2024	49	49	22
Mar 2024	74	76	52
Total	4089	4202	1622